Zinc oxide protects cultured enterocytes from the damage induced by Escherichia coli.
There is some evidence that zinc oxide (ZnO) protects against intestinal diseases. However, despite the suggestions that ZnO may have an antibacterial effect, the mechanisms of this protective effect have not yet been elucidated. We investigated the potential benefits of ZnO in protecting intestinal cells from damage induced by enterotoxigenic Escherichia coli (ETEC, strain K88) and the related mechanisms, using human Caco-2 enterocytes. Cell permeability, measured as transepithelial electrical resistance (TEER), was unaffected by 0.01 and 1 mmol/L ZnO treatments and moderately increased by 5 mmol/L ZnO, compared with untreated cells. Transfer of (14)C-inulin was slightly increased by 5 mmol/L ZnO compared with untreated cells; transfer was unaffected by lower concentrations. The TEER and (14)C-inulin transfer were lower in ETEC-infected cells than in uninfected cells. Treatment of ETEC exposure with 0.2 mmol/L ZnO prevented disruption of membrane integrity. The ETEC was able to adhere to enterocytes and, to some extent, invade the cells. The ZnO treatment reduced bacterial adhesion and blocked bacterial invasion. The ETEC infection upregulated the expression of the inflammatory cytokines interleukin-8, growth-related oncogene-alpha and tumor necrosis factor-alpha, and reduced that of the anti-inflammatory cytokine transforming growth factor-beta, compared with uninfected cells. The addition of 0.2 or 1 mmol/L ZnO counteracted the alteration of cytokine mRNA levels caused by ETEC. The protective effects of ZnO were not due to any antibacterial activity, because the viability of ETEC grown in a medium containing ZnO was unaffected. In conclusion, ZnO may protect intestinal cells from ETEC infection by inhibiting the adhesion and internalization of bacteria, preventing the increase of tight junction permeability and modulating cytokine gene expression.
Roselli
Marianna
M
Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione (INRAN), Via Ardeatina 546, 00178 Rome, Italy.
Finamore
Alberto
A
Garaguso
Ivana
I
Britti
Maria Serena
MS
Mengheri
Elena
E
D001422:Bacterial Adhesion / Q000187:drug effects; D018938:Caco-2 Cells; D016207:Cytokines / Q000235:genetics; D019610:Cytoprotection; D020895:Enterocytes / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology*; D004768:Enterotoxins / Q000096:biosynthesis; D004926:Escherichia coli / Q000187:drug effects / Q000502:physiology; D004927:Escherichia coli Infections / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D010539:Permeability / Q000187:drug effects; D019108:Tight Junctions / Q000378:metabolism; D015034:Zinc Oxide / Q000494:pharmacology*
D016207:Cytokines; D004768:Enterotoxins; D015034:Zinc Oxide